Related Experiment Video
Updated: Apr 25, 2026

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
Helicobacter pylori infection in pediatrics
Barbara Iwańczak1, Ruggiero Francavailla
1Department of Pediatrics, Gastroenterology and Nutrition, Medical University of Wroclaw, Wrocław, Poland.
Pediatric Helicobacter pylori infection risk factors include parental origin and childcare settings. Early infection may increase adult gastric cancer risk, underscoring the need for prevention programs.
Area of Science:
- Pediatric Gastroenterology
- Infectious Diseases
- Oncology
Background:
- Recent pediatric studies highlight differences in gastric Th1 cytokine secretion compared to adults.
- Helicobacter pylori infection in children is linked to parental origin and high-prevalence childcare settings.
- A potential association between childhood H. pylori infection and adult gastric cancer risk is proposed.
Purpose of the Study:
- To review recent pediatric studies on Helicobacter pylori infection.
- To explore H. pylori's role in pediatric conditions like iron-deficiency anemia.
- To examine antibiotic resistance and treatment efficacy in pediatric H. pylori infections.
Main Methods:
- Review of pediatric studies published between April 2013 and March 2014.
- Analysis of pathogenesis data, risk factors, and clinical associations.
- Evaluation of research on antibiotic resistance and treatment outcomes.
Main Results:
- Children exhibit less intense gastric Th1 cytokine secretion than adults.
- Parental origin and childcare settings are key risk factors for H. pylori infection.
- Evidence supports H. pylori's role in pediatric iron-deficiency anemia.
- Increased antibiotic resistance is confirmed, necessitating further investigation into PPI metabolism and CYP2C19 polymorphism.
- Probiotic supplementation shows promise in improving eradication rates and reducing side effects like diarrhea.
Conclusions:
- Preventive programs are crucial to reduce the burden of childhood H. pylori infection in endemic areas.
- Further research is needed on CYP2C19 genetic polymorphism's impact on proton-pump inhibitor efficacy.
- Probiotics may offer benefits for H. pylori eradication and managing therapy-related side effects in children.
More Related Videos
03:47Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
Published on: November 1, 2024
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Related Concept Videos
Peptic Ulcer
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Gastritis II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.